Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.71M Buy
12,444
+495
+4% +$110K 0.1% 93
2025
Q4
$2.73M Buy
11,949
+508
+4% +$116K 0.1% 92
2025
Q3
$2.65M Buy
11,441
+677
+6% +$138K 0.11% 95
2025
Q2
$2M Buy
10,764
+494
+5% +$91.8K 0.09% 107
2025
Q1
$2.15M Buy
10,270
+695
+7% +$135K 0.11% 97
2024
Q4
$1.7M Buy
9,575
+363
+4% +$66.7K 0.09% 106
2024
Q3
$1.82M Buy
9,212
+436
+5% +$81.4K 0.09% 101
2024
Q2
$1.5M Buy
+8,776
New +$1.45M 0.08% 102

Other funds holding ABBV

Aviso Financial's ABBV Position: Q1 2026 in Review

Aviso Financial increased its AbbVie (ABBV) stake by 4.1% in Q1 2026, buying an estimated $110K and bringing the position to 12,444 shares worth $2.71M. The position accounts for 0.1% of the portfolio, ranked #93.

Aviso Financial first reported a position in ABBV in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.73M in Q4 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Aviso Financial held 12,444 shares of AbbVie worth $2.71M as of Q1 2026.
  • Aviso Financial bought 495 AbbVie shares in Q1 2026, an estimated $110K.
  • AbbVie made up 0.1% of Aviso Financial's portfolio in Q1 2026, its #93 holding.
  • Aviso Financial first reported a position in AbbVie in Q2 2024 and has held it in 8 quarters since.
  • Aviso Financial's AbbVie position peaked at $2.73M in Q4 2025.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Aviso Financial's 13F filing for Q1 2026, filed 14 May 2026.